Related Experiment Video
Updated: Mar 7, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Left cardiac sympathetic denervation: case series and technical report
C McNamara1, P Cullen1, M Rackauskas1
1Department of Cardiothoracic Surgery, Mater Misericordiae University Hospital, Eccles St., Dublin 7, Ireland.
Left cardiac sympathetic denervation (LCSD) is a safe and effective treatment for refractory arrhythmias, particularly in pediatric and adult patients with channelopathies and cardiomyopathies. This minimally invasive surgery offers significant benefits, improving outcomes for those with life-threatening conditions.
Area of Science:
- Cardiovascular Surgery
- Electrophysiology
- Thoracic Surgery
Background:
- Left cardiac sympathetic denervation (LCSD) has a long-standing history of antiarrhythmic and antifibrillatory effects.
- Advancements in Video-Assisted Thoracoscopic Surgery (VATS) enable minimally invasive LCSD with reduced morbidity and shorter hospital stays.
- LCSD is a crucial therapeutic option for patients suffering from life-threatening channelopathies and cardiomyopathies.
More Related Videos
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy